Received Feb 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X018273 | — |
No additional AE/PQC reported; Medical Assistant calling with a report of an adverse event regarding an expired dose of PNEUMOVAX 23 that was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-JAN-2025, the patient was vaccinated with an expired dose of pneumococcal 23v polysaccharide vaccine (PNEUMOVAX23) injection, 0.5 milliliter, lot #X018273, expiration date: 07-OCT-2024, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). Medical Assistant confirmed the patient involved had not had any medical concerns or symptoms after the administration of the expired dose of the vaccine.